Skip to content

Clinical trials

Completed Phase 1 Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 1 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20101
20112
20121
20141
20171
20182
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.4
GlaxoSmithKline2
Bioverativ, a Sanofi company1
Chongqing Peg-Bio Biopharm Co., Ltd.1
Genentech, Inc.1
Hospital Civil de Guadalajara1
Hutchison Medipharma Limited1
Jiangsu HengRui Medicine Co., Ltd.1
Mayo Clinic1
Staidson (Beijing) Biopharmaceuticals Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic14
Autoimmune Diseases1
Blood Platelet Disorders1
HIV Infections1
Hematologic Diseases1
Immune System Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.